source
- FDA clears Edwards' tricuspid valve repair device; Bayer's blood thinner asundexian approved in ChinaThe U.S. Food and Drug Administration has granted approval for Edwards Lifesciences' new tricuspid valve repair system, expanding treatment options for patients with tricuspid regurgitation. In Ch…
- Corxel opts for SPAC merger to take oral obesity drug public on NasdaqCorxel Pharmaceuticals, an obesity-focused biotech, said it will merge with Amanat Acquisition in the first half of next year to become a publicly traded company on Nasdaq. The company’s CFO noted…